Literature DB >> 18361430

Calibration of credibility of agnostic genome-wide associations.

John P A Ioannidis1.   

Abstract

Genome-wide testing platforms are increasingly used to promote "agnostic" approaches to the discovery of gene variants associated with the risk of many common diseases and quantitative traits. The early track record of genome-wide association (GWA) studies suggests that some proposed associations are replicated quite consistently with large-scale subsequent evidence from multiple studies, others have a more inconsistent replication record, some have failed to be replicated by independent investigators and many more early proposed associations await further replication. An important question is how to calibrate the credibility of these postulated associations. A simple Bayesian method is applied here to achieve such calibration. The variability of the estimated credibility is examined under different assumptions. Empirical examples are drawn from existing GWA studies. It is demonstrated that the credibility of different proposed associations can cover a very wide range. The credibility of specific associations usually remains relatively robust when different plausible assumptions are made (within a reasonable range) for the prior odds of an association being true, or the magnitude of the anticipated effect size for genetic associations. Heterogeneity and bias assumptions can have a more major impact on the credibility estimates and thus they need very careful consideration in each case. Credibility calibration may be used in conjunction with qualitative criteria for the appraisal of the cumulative evidence that take into consideration the amount, consistency, and protection from bias in the data. 2008 Wiley-Liss, Inc.

Mesh:

Year:  2008        PMID: 18361430     DOI: 10.1002/ajmg.b.30721

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

1.  Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies.

Authors:  Konstantinos C M Siontis; Nikolaos A Patsopoulos; John P A Ioannidis
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

Review 2.  Genetic epidemiology of hip and knee osteoarthritis.

Authors:  Ana M Valdes; Tim D Spector
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

Review 3.  Cancer evolution and individual susceptibility.

Authors:  Jesús Pérez-Losada; Andrés Castellanos-Martín; Jian-Hua Mao
Journal:  Integr Biol (Camb)       Date:  2011-01-24       Impact factor: 2.192

4.  Distinguishing true from false positives in genomic studies: p values.

Authors:  Linda Broer; Christina M Lill; Maaike Schuur; Najaf Amin; Johannes T Roehr; Lars Bertram; John P A Ioannidis; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2013-02-01       Impact factor: 8.082

5.  Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases.

Authors:  Muin J Khoury; Lars Bertram; Paolo Boffetta; Adam S Butterworth; Stephen J Chanock; Siobhan M Dolan; Isabel Fortier; Montserrat Garcia-Closas; Marta Gwinn; Julian P T Higgins; A Cecile J W Janssens; James Ostell; Ryan P Owen; Roberta A Pagon; Timothy R Rebbeck; Nathaniel Rothman; Jonine L Bernstein; Paul R Burton; Harry Campbell; Anand Chockalingam; Helena Furberg; Julian Little; Thomas R O'Brien; Daniela Seminara; Paolo Vineis; Deborah M Winn; Wei Yu; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2009-06-04       Impact factor: 4.897

Review 6.  Meta-analysis in genome-wide association studies.

Authors:  Eleftheria Zeggini; John P A Ioannidis
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

7.  Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.

Authors:  Evangelos Evangelou; Kay Chapman; Ingrid Meulenbelt; Fotini B Karassa; John Loughlin; Andrew Carr; Michael Doherty; Sally Doherty; Juan J Gómez-Reino; Antonio Gonzalez; Bjarni V Halldorsson; Valdimar B Hauksson; Albert Hofman; Deborah J Hart; Shiro Ikegawa; Thorvaldur Ingvarsson; Qing Jiang; Ingileif Jonsdottir; Helgi Jonsson; Hanneke J M Kerkhof; Margreet Kloppenburg; Nancy E Lane; Jia Li; Rik J Lories; Joyce B J van Meurs; Annu Näkki; Michael C Nevitt; Julio Rodriguez-Lopez; Dongquan Shi; P Eline Slagboom; Kari Stefansson; Aspasia Tsezou; Gillian A Wallis; Christopher M Watson; Tim D Spector; Andre G Uitterlinden; Ana M Valdes; John P A Ioannidis
Journal:  Arthritis Rheum       Date:  2009-06

8.  Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study.

Authors:  Evangelos Evangelou; Demetrius M Maraganore; Grazia Annesi; Laura Brighina; Alexis Brice; Alexis Elbaz; Carlo Ferrarese; Georgios M Hadjigeorgiou; Rejko Krueger; Jean-Charles Lambert; Suzanne Lesage; Katerina Markopoulou; George D Mellick; Bram Meeus; Nancy L Pedersen; Aldo Quattrone; Christine Van Broeckhoven; Manu Sharma; Peter A Silburn; Eng-King Tan; Karin Wirdefeldt; John P A Ioannidis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

Review 9.  Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer.

Authors:  Antonella Galvan; John P A Ioannidis; Tommaso A Dragani
Journal:  Trends Genet       Date:  2010-01-26       Impact factor: 11.639

10.  Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.

Authors:  A M Valdes; G Thomson; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-07       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.